BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 19303127)

  • 1. Rejection of pharmaceutically active compounds and endocrine disrupting compounds by clean and fouled nanofiltration membranes.
    Yangali-Quintanilla V; Sadmani A; McConville M; Kennedy M; Amy G
    Water Res; 2009 May; 43(9):2349-62. PubMed ID: 19303127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rejection of pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) by low pressure reverse osmosis membranes.
    Ozaki H; Ikejima N; Shimizu Y; Fukami K; Taniguchi S; Takanami R; Giri RR; Matsui S
    Water Sci Technol; 2008; 58(1):73-81. PubMed ID: 18653939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A QSAR model for predicting rejection of emerging contaminants (pharmaceuticals, endocrine disruptors) by nanofiltration membranes.
    Yangali-Quintanilla V; Sadmani A; McConville M; Kennedy M; Amy G
    Water Res; 2010 Jan; 44(2):373-84. PubMed ID: 19616272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rejection of micropollutants by clean and fouled forward osmosis membrane.
    Valladares Linares R; Yangali-Quintanilla V; Li Z; Amy G
    Water Res; 2011 Dec; 45(20):6737-44. PubMed ID: 22055122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of fouling resistant nanofiltration and reverse osmosis membranes for dyeing wastewater effluent treatment.
    Myung SW; Choi IH; Lee SH; Kim IC; Lee KH
    Water Sci Technol; 2005; 51(6-7):159-64. PubMed ID: 16003974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of natural organic matter and cations on the rejection of endocrine disrupting and pharmaceutically active compounds by nanofiltration.
    Comerton AM; Andrews RC; Bagley DM
    Water Res; 2009 Feb; 43(3):613-22. PubMed ID: 19046596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of electrostatic interactions on the rejection with NF and assessment of the removal efficiency during NF/GAC treatment of pharmaceutically active compounds in surface water.
    Verliefde AR; Heijman SG; Cornelissen ER; Amy G; Van der Bruggen B; van Dijk JC
    Water Res; 2007 Aug; 41(15):3227-40. PubMed ID: 17583761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejection of trace organic compounds by high-pressure membranes.
    Kim TU; Amy G; Drewes JE
    Water Sci Technol; 2005; 51(6-7):335-44. PubMed ID: 16003994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fouling of reverse osmosis and nanofiltration membranes by dairy industry effluents.
    Turan M; Ates A; Inanc B
    Water Sci Technol; 2002; 45(12):355-60. PubMed ID: 12201123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying the rejection mechanism for nanofiltration membranes fouled by humic acid and calcium ions exemplified by acetaminophen, sulfamethoxazole, and triclosan.
    Chang EE; Chang YC; Liang CH; Huang CP; Chiang PC
    J Hazard Mater; 2012 Jun; 221-222():19-27. PubMed ID: 22554383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
    Kimura K; Iwase T; Kita S; Watanabe Y
    Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of silica fouling on the removal of pharmaceuticals and personal care products by nanofiltration and reverse osmosis membranes.
    Lin YL; Chiou JH; Lee CH
    J Hazard Mater; 2014 Jul; 277():102-9. PubMed ID: 24560524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing algogenic organic matter (AOM) and evaluating associated NF membrane fouling.
    Her N; Amy G; Park HR; Song M
    Water Res; 2004 Mar; 38(6):1427-38. PubMed ID: 15016519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct observation of bacterial deposition onto clean and organic-fouled polyamide membranes.
    Subramani A; Huang X; Hoek EM
    J Colloid Interface Sci; 2009 Aug; 336(1):13-20. PubMed ID: 19406423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing dissolved organic matter and evaluating associated nanofiltration membrane fouling.
    Her N; Amy G; Chung J; Yoon J; Yoon Y
    Chemosphere; 2008 Jan; 70(3):495-502. PubMed ID: 17662337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterising humic acid fouling of nanofiltration membranes using bisphenol A as a molecular indicator.
    Nghiem LD; Vogel D; Khan S
    Water Res; 2008 Sep; 42(15):4049-58. PubMed ID: 18678386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface characterisation of biofouled NF membranes: role of surface energy for improved rejection predictions.
    Botton S; Verliefde AR; Quach NT; Cornelissen ER
    Water Sci Technol; 2012; 66(10):2122-30. PubMed ID: 22949242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rejection of pharmaceuticals by forward osmosis membranes.
    Jin X; Shan J; Wang C; Wei J; Tang CY
    J Hazard Mater; 2012 Aug; 227-228():55-61. PubMed ID: 22640821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
    Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
    Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of endocrine disrupting chemicals (EDCs) using low pressure reverse osmosis membrane (LPROM).
    Razak AR; Ujang Z; Ozaki H
    Water Sci Technol; 2007; 56(8):161-8. PubMed ID: 17978444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.